{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:14:25Z","timestamp":1791825265630,"version":"4.3.4"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Metab Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The liver is the principal organ responsible for maintaining systemic glucose homeostasis through the integrated regulation of gluconeogenesis, glycogenolysis, glycogenesis, and glycolysis. As fasting progresses and hepatic glycogen stores decline, gluconeogenesis becomes the dominant source of endogenous glucose production required to preserve euglycemia. This review summarizes the regulation of gluconeogenesis and discusses the clinical manifestations, diagnostic implications, and therapeutic relevance of gluconeogenic dysfunction across diverse disease states.<\/jats:p>","DOI":"10.1038\/s44324-026-00120-6","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:00:31Z","timestamp":1784638831000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Regulation and clinical manifestations of gluconeogenesis dysfunction"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3478-5195","authenticated-orcid":false,"given":"Natalia","family":"Bobok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"120_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2337\/diabetes.48.2.292","volume":"48","author":"K Ekberg","year":"1999","unstructured":"Ekberg, K. et al. Contributions by kidney and liver to glucose production in the postabsorptive state and after 60h of fasting. Diabetes 48, 292\u2013300 (1999).","journal-title":"Diabetes"},{"key":"120_CR2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nrendo.2017.80","volume":"13","author":"MC Petersen","year":"2017","unstructured":"Petersen, M. C., Vatner, D. F. & Shulman, G. I. Regulation of hepatic glucose metabolism in health and disease. Nat. Rev. Endocrinol. 13, 572\u2013587 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"120_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-024-00437-2","volume":"10","author":"Y Pan","year":"2024","unstructured":"Pan, Y. et al. Time and dose selective glucose metabolism for glucose homeostasis and energy conversion in the liver. npj Syst. Biol. Appl. 10, 107 (2024).","journal-title":"npj Syst. Biol. Appl."},{"key":"120_CR4","doi-asserted-by":"publisher","first-page":"R99","DOI":"10.1530\/JOE-16-0021","volume":"229","author":"H Wu","year":"2016","unstructured":"Wu, H. et al. PGC-1\u03b1, glucose metabolism and type 2 diabetes mellitus. J. Endocrinol. 229, R99\u2013R115 (2016).","journal-title":"J. Endocrinol."},{"key":"120_CR5","unstructured":"Patino, S. C. & Orrick, J. A. Biochemistry\u2014glycogenolysis. in StatPearls (StatPearls Publishing, Treasure Island, FL, 2024)."},{"key":"120_CR6","doi-asserted-by":"publisher","first-page":"107906","DOI":"10.1016\/j.jbc.2024.107906","volume":"300","author":"SJ Kierans","year":"2024","unstructured":"Kierans, S. J. & Taylor, C. T. Glycolysis: a multifaceted metabolic pathway and signaling hub. J. Biol. Chem. 300, 107906 (2024).","journal-title":"J. Biol. Chem."},{"key":"120_CR7","unstructured":"Melkonian, E. A., Asuka, E. & Schury, M. P. Physiology, gluconeogenesis. in StatPearls (StatPearls Publishing, Treasure Island, FL, 2023)."},{"key":"120_CR8","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3389\/fendo.2018.00802","volume":"9","author":"X Zhang","year":"2019","unstructured":"Zhang, X., Yang, S., Chen, J. & Su, Z. Unraveling the regulation of hepatic gluconeogenesis. Front. Endocrinol. 9, 802 (2019).","journal-title":"Front. Endocrinol."},{"key":"120_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3390\/nu13010159","volume":"13","author":"GD Dimitriadis","year":"2021","unstructured":"Dimitriadis, G. D., Maratou, E., Kountouri, A., Board, M. & Lambadiari, V. Regulation of postabsorptive and postprandial glucose metabolism by insulin-dependent and insulin-independent mechanisms: an integrative approach. Nutrients 13, 159 (2021).","journal-title":"Nutrients"},{"key":"120_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.dsx.2020.11.021","volume":"15","author":"S Kubihal","year":"2021","unstructured":"Kubihal, S., Goyal, A., Gupta, Y. & Khadgawat, R. Glucose measurement in body fluids: a ready reckoner for clinicians. Diab. Metab. Syndr. 15, 45\u201353 (2021).","journal-title":"Diab. Metab. Syndr."},{"key":"120_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-0908-7","volume":"19","author":"JS Krinsley","year":"2015","unstructured":"Krinsley, J. S. & Preiser, J. C. Time in blood glucose range 70 to 140mg\/dl >80% is strongly associated with increased survival in non-diabetic critically ill adults. Crit. Care 19, 179 (2015).","journal-title":"Crit. Care"},{"key":"120_CR12","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino, T. et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diab. Care 42, 1593\u20131603 (2019).","journal-title":"Diab. Care"},{"key":"120_CR13","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/19336934.2017.1283081","volume":"11","author":"T Miyamoto","year":"2017","unstructured":"Miyamoto, T. & Amrein, H. Gluconeogenesis: an ancient biochemical pathway with a new twist. Fly 11, 218\u2013223 (2017).","journal-title":"Fly"},{"key":"120_CR14","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1093\/jn\/nxaa166","volume":"150","author":"MA Tetrick","year":"2020","unstructured":"Tetrick, M. A. & Odle, J. What constitutes a gluconeogenic precursor? J. Nutr. 150, 2239\u20132241 (2020).","journal-title":"J. Nutr."},{"key":"120_CR15","doi-asserted-by":"publisher","first-page":"e188363","DOI":"10.1172\/JCI188363","volume":"135","author":"B Zhang","year":"2025","unstructured":"Zhang, B. et al. Hepatic glycogen directly regulates gluconeogenesis through an AMPK\/CRTC2 axis in mice. J. Clin. Invest. 135, e188363 (2025).","journal-title":"J. Clin. Invest."},{"key":"120_CR16","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/pedi.13443","volume":"23","author":"MB Abraham","year":"2022","unstructured":"Abraham, M. B. et al. ISPAD Clinical Practice Consensus Guidelines 2022: assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr. Diab. 23, 1322\u20131340 (2022).","journal-title":"Pediatr. Diab."},{"key":"120_CR17","doi-asserted-by":"publisher","first-page":"E914","DOI":"10.1152\/ajpendo.00501.2020","volume":"320","author":"SO Warner","year":"2021","unstructured":"Warner, S. O. et al. Liver glycogen-induced enhancements in hypoglycemic counterregulation require neuroglucopenia. Am. J. Physiol. Endocrinol. Metab. 320, E914\u2013E924 (2021).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"120_CR18","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.3390\/jcm14134393","volume":"14","author":"E Looi","year":"2025","unstructured":"Looi, E. & Lawler, H. M. Non-diabetic hypoglycemia: evaluation and management in adults. J. Clin. Med. 14, 4393 (2025).","journal-title":"J. Clin. Med."},{"key":"120_CR19","doi-asserted-by":"publisher","first-page":"155614","DOI":"10.1016\/j.metabol.2023.155614","volume":"145","author":"M Hole\u010dek","year":"2023","unstructured":"Hole\u010dek, M. Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states. Metabolism 145, 155614 (2023).","journal-title":"Metabolism"},{"key":"120_CR20","doi-asserted-by":"publisher","first-page":"110261","DOI":"10.1016\/j.jbc.2025.110261","volume":"301","author":"BD Fink","year":"2025","unstructured":"Fink, B. D. et al. Hepatic glutamic-oxaloacetic transaminase promotes mitochondrial respiration energized at complex II and alters whole body metabolism. J. Biol. Chem. 301, 110261 (2025).","journal-title":"J. Biol. Chem."},{"key":"120_CR21","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1002\/iub.2367","volume":"72","author":"P Borst","year":"2020","unstructured":"Borst, P. The malate-aspartate shuttle (Borst cycle): How it started and developed into a major metabolic pathway. IUBMB Life 72, 2241\u20132259 (2020).","journal-title":"IUBMB Life"},{"key":"120_CR22","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.molcel.2015.09.025","volume":"60","author":"ED Montal","year":"2015","unstructured":"Montal, E. D. et al. PEPCK coordinates the regulation of central carbon metabolism to promote cancer cell growth. Mol. Cell 60, 571\u2013583 (2015).","journal-title":"Mol. Cell"},{"key":"120_CR23","doi-asserted-by":"publisher","first-page":"BSR20190124","DOI":"10.1042\/BSR20190124","volume":"39","author":"DJ Timson","year":"2019","unstructured":"Timson, D. J. Fructose 1,6-bisphosphatase: getting the message across. Biosci. Rep. 39, BSR20190124 (2019).","journal-title":"Biosci. Rep."},{"key":"120_CR24","doi-asserted-by":"publisher","first-page":"e2418316122","DOI":"10.1073\/pnas.2418316122","volume":"122","author":"Z Xia","year":"2025","unstructured":"Xia, Z. et al. Structural insights into glucose-6-phosphate recognition and hydrolysis by human G6PC1. Proc. Natl. Acad. Sci. USA 122, e2418316122 (2025).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"120_CR25","doi-asserted-by":"publisher","unstructured":"Wattanavanitchakorn, S. & Jitrapakdee, S. Gluconeogenesis. eLS (John Wiley & Sons, 2016). https:\/\/doi.org\/10.1002\/9780470015902.a0000627.pub3.","DOI":"10.1002\/9780470015902.a0000627.pub3"},{"key":"120_CR26","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3389\/fphar.2016.00521","volume":"7","author":"J Yip","year":"2017","unstructured":"Yip, J., Geng, X., Shen, J. & Ding, Y. Cerebral gluconeogenesis and diseases. Front. Pharmacol. 7, 521 (2017).","journal-title":"Front. Pharmacol."},{"key":"120_CR27","first-page":"100889","volume":"32","author":"P Tsygankova","year":"2022","unstructured":"Tsygankova, P. et al. Expanding the genetic spectrum of pyruvate carboxylase deficiency with novel missense, deep intronic and structural variants. Mol. Genet. Metab. Rep. 32, 100889 (2022).","journal-title":"Mol. Genet. Metab. Rep."},{"key":"120_CR28","unstructured":"Duque Lasio, M. L. et al. Pyruvate carboxylase deficiency. in GeneReviews\u00ae (University of Washington, 2024 update)."},{"key":"120_CR29","first-page":"101175","volume":"42","author":"D Burg","year":"2024","unstructured":"Burg, D. et al. Cytosolic PEPCK deficiency caused by a novel homozygous frameshift variant presenting as resolved hypoglycemia and acute liver failure at birth. Mol. Genet. Metab. Rep. 42, 101175 (2024).","journal-title":"Mol. Genet. Metab. Rep."},{"key":"120_CR30","doi-asserted-by":"publisher","first-page":"e943118","DOI":"10.12659\/AJCR.943118","volume":"25","author":"M Du\u015b-\u017buchowska","year":"2024","unstructured":"Du\u015b-\u017buchowska, M. et al. Pathogenic potential of a PCK1 gene variant in cytosolic PEPCK deficiency. Am. J. Case Rep. 25, e943118 (2024).","journal-title":"Am. J. Case Rep."},{"key":"120_CR31","doi-asserted-by":"publisher","first-page":"1296797","DOI":"10.3389\/fgene.2024.1296797","volume":"15","author":"Q Ni","year":"2024","unstructured":"Ni, Q. et al. Fructose-1,6-bisphosphatase deficiency: estimation of prevalence in the Chinese population and genotype\u2013phenotype correlation. Front. Genet. 15, 1296797 (2024).","journal-title":"Front. Genet."},{"key":"120_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-025-04100-9","volume":"20","author":"SM Elsayed","year":"2025","unstructured":"Elsayed, S. M. et al. Clinical and molecular characteristics of fructose-1,6-bisphosphatase deficiency in Egyptian patients. Orphanet. J. Rare Dis. 20, 595 (2025).","journal-title":"Orphanet. J. Rare Dis."},{"key":"120_CR33","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s42003-023-05160-y","volume":"6","author":"I Sakuma","year":"2023","unstructured":"Sakuma, I. et al. Genotype\u2013biochemical phenotype correlations in fructose 1,6-bisphosphatase deficiency. Commun. Biol. 6, 787 (2023).","journal-title":"Commun. Biol."},{"key":"120_CR34","doi-asserted-by":"publisher","first-page":"e2339","DOI":"10.1002\/mgg3.2339","volume":"12","author":"B Xin","year":"2024","unstructured":"Xin, B. et al. Novel compound heterozygous mutations of the FBP1 gene in hypoglycemia and lactic acidosis. Mol. Genet. Genom. Med. 12, e2339 (2024).","journal-title":"Mol. Genet. Genom. Med."},{"key":"120_CR35","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/humu.20772","volume":"29","author":"JY Chou","year":"2008","unstructured":"Chou, J. Y. & Mansfield, B. C. Mutations in the glucose-6-phosphatase-\u03b1 (G6PC) gene that cause type Ia glycogen storage disease. Hum. Mutat. 29, 921\u2013930 (2008).","journal-title":"Hum. Mutat."},{"key":"120_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42188-4","volume":"14","author":"T Onodera","year":"2023","unstructured":"Onodera, T. et al. Endogenous renal adiponectin drives gluconeogenesis through enhancing pyruvate and fatty acid utilization. Nat. Commun. 14, 6531 (2023).","journal-title":"Nat. Commun."},{"key":"120_CR37","unstructured":"Chourpiliadis, C. & Mohiuddin, S. S. Biochemistry, gluconeogenesis. in StatPearls (StatPearls Publishing, 2026)."},{"key":"120_CR38","doi-asserted-by":"publisher","first-page":"e01131-24","DOI":"10.1128\/msystems.01131-24","volume":"10","author":"F She","year":"2025","unstructured":"She, F. et al. Allosteric regulation of pyruvate kinase enables efficient and robust gluconeogenesis by preventing metabolic conflicts and carbon overflow. mSystems 10, e01131-24 (2025).","journal-title":"mSystems"},{"key":"120_CR39","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.molmet.2019.11.005","volume":"31","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Kwon, H., Su, X. & Wondisford, F. E. Glycerol is the major net carbon source for gluconeogenesis in mice during fasting. Mol. Metab. 31, 36\u201344 (2020).","journal-title":"Mol. Metab."},{"key":"120_CR40","doi-asserted-by":"publisher","first-page":"155214","DOI":"10.1016\/j.metabol.2022.155214","volume":"132","author":"A Shah","year":"2022","unstructured":"Shah, A. et al. Glycerol\u2019s contribution to lactate production outside a glucose intermediate in fasting humans. Metabolism 132, 155214 (2022).","journal-title":"Metabolism"},{"key":"120_CR41","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3390\/metabo12100890","volume":"12","author":"A Shah","year":"2022","unstructured":"Shah, A., Wang, Y. & Wondisford, F. E. Differential metabolism of glycerol based on oral versus intravenous administration in humans. Metabolites 12, 890 (2022).","journal-title":"Metabolites"},{"key":"120_CR42","doi-asserted-by":"publisher","first-page":"E685","DOI":"10.1152\/ajpendo.00253.2003","volume":"285","author":"A Barthel","year":"2003","unstructured":"Barthel, A. & Schmoll, D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am. J. Physiol. Endocrinol. Metab. 285, E685\u2013E692 (2003).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"120_CR43","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.2337\/db22-0079","volume":"71","author":"H James","year":"2022","unstructured":"James, H. et al. The effect of glucagon on protein catabolism during insulin deficiency: exchange of amino acids across skeletal muscle and the splanchnic bed. Diabetes 71, 1636\u20131648 (2022).","journal-title":"Diabetes"},{"key":"120_CR44","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1152\/physrev.00028.2023","volume":"104","author":"S Kajani","year":"2024","unstructured":"Kajani, S., Laker, R. C., Ratkova, E., Will, S. & Rhodes, C. J. Hepatic glucagon action: beyond glucose mobilization. Physiol. Rev. 104, 1021\u20131060 (2024).","journal-title":"Physiol. Rev."},{"key":"120_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.clnesp.2021.06.025","volume":"44","author":"MM Adeva-Andany","year":"2021","unstructured":"Adeva-Andany, M. M. et al. The effects of glucagon and the target of rapamycin (TOR) on skeletal muscle protein synthesis and age-dependent sarcopenia in humans. Clin. Nutr. ESPEN 44, 15\u201325 (2021).","journal-title":"Clin. Nutr. ESPEN"},{"key":"120_CR46","first-page":"45","volume":"15","author":"MM Adeva-Andany","year":"2018","unstructured":"Adeva-Andany, M. M. et al. Metabolic effects of glucagon in humans. J. Clin. Transl. Endocrinol. 15, 45\u201353 (2018).","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"120_CR47","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-4939-2895-8_5","volume":"872","author":"T Kuo","year":"2015","unstructured":"Kuo, T., McQueen, A., Chen, T. C. & Wang, J. C. Regulation of glucose homeostasis by glucocorticoids. Adv. Exp. Med. Biol. 872, 99\u2013126 (2015).","journal-title":"Adv. Exp. Med. Biol."},{"key":"120_CR48","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1210\/me.2004-0497","volume":"19","author":"BT Vander Kooi","year":"2005","unstructured":"Vander Kooi, B. T. et al. The glucose-6-phosphatase catalytic subunit gene promoter contains both positive and negative glucocorticoid response elements. Mol. Endocrinol. 19, 3001\u20133022 (2005).","journal-title":"Mol. Endocrinol."},{"key":"120_CR49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1210\/endrev\/bnaf030","volume":"47","author":"M Chang","year":"2026","unstructured":"Chang, M. & Wang, J. C. Hepatic glucocorticoid receptor action and glucose homeostasis. Endocr. Rev. 47, 52\u201374 (2026).","journal-title":"Endocr. Rev."},{"key":"120_CR50","doi-asserted-by":"publisher","first-page":"11173","DOI":"10.3390\/ijms222011173","volume":"22","author":"I Kokkinopoulou","year":"2021","unstructured":"Kokkinopoulou, I., Diakoumi, A. & Moutsatsou, P. Glucocorticoid receptor signaling in diabetes. Int. J. Mol. Sci. 22, 11173 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"120_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.51511\/pr.1","volume":"1","author":"DA Sari","year":"2021","unstructured":"Sari, D. A., Samodra, G. & Kusuma, I. Y. Molecular mechanism of glucocorticoid-induced hyperglycemia. Pharm. Rep. 1, 1 (2021).","journal-title":"Pharm. Rep."},{"key":"120_CR52","doi-asserted-by":"publisher","first-page":"6123","DOI":"10.1093\/nar\/gkac358","volume":"50","author":"D Goldberg","year":"2022","unstructured":"Goldberg, D. et al. Hormone-controlled cooperative transcription factor binding in fasting genes. Nucleic Acids Res. 50, 6123\u20136138 (2022).","journal-title":"Nucleic Acids Res."},{"key":"120_CR53","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41574-022-00683-6","volume":"18","author":"JX Li","year":"2022","unstructured":"Li, J. X. & Cummins, C. L. Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions. Nat. Rev. Endocrinol. 18, 540\u2013557 (2022).","journal-title":"Nat. Rev. Endocrinol."},{"key":"120_CR54","doi-asserted-by":"publisher","first-page":"e14370","DOI":"10.14814\/phy2.14370","volume":"8","author":"HA Dibe","year":"2020","unstructured":"Dibe, H. A. et al. Epinephrine responsiveness in trained mouse liver. Physiol. Rep. 8, e14370 (2020).","journal-title":"Physiol. Rep."},{"key":"120_CR55","doi-asserted-by":"publisher","first-page":"eadi3624","DOI":"10.1126\/science.adi3624","volume":"387","author":"M \u0160estan","year":"2025","unstructured":"\u0160estan, M. et al. Neuronal-ILC2 interactions regulate pancreatic glucagon and glucose homeostasis. Science 387, eadi3624 (2025).","journal-title":"Science"},{"key":"120_CR56","doi-asserted-by":"publisher","first-page":"E522","DOI":"10.1532\/hsf.2008","volume":"21","author":"D Phadke","year":"2018","unstructured":"Phadke, D., Beller, J. P. & Tribble, C. The disparate effects of epinephrine and norepinephrine on hyperglycemia in cardiovascular surgery. Heart Surg. Forum 21, E522\u2013E526 (2018).","journal-title":"Heart Surg. Forum"},{"key":"120_CR57","doi-asserted-by":"publisher","first-page":"728","DOI":"10.2337\/db22-0718","volume":"72","author":"KZ Rokamp","year":"2023","unstructured":"Rokamp, K. Z. et al. Impact of polymorphism in the \u03b22-receptor gene on the metabolic response to epinephrine after repeated hypoglycemia. Diabetes 72, 728\u2013734 (2023).","journal-title":"Diabetes"},{"key":"120_CR58","doi-asserted-by":"publisher","first-page":"e1940","DOI":"10.1210\/clinem\/dgae123","volume":"109","author":"F Alhenc-Gelas","year":"2024","unstructured":"Alhenc-Gelas, F. & Marre, M. Young-onset type 2 diabetes: when gluconeogenesis is overfueled and out of control. J. Clin. Endocrinol. Metab. 109, e1940\u2013e1941 (2024).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"120_CR59","first-page":"63","volume":"33","author":"W Tang","year":"2026","unstructured":"Tang, W. et al. Influence and treatment of insulin receptor substrate\/PI3K\/Akt-mediated insulin resistance in diabetes mellitus. Mol. Med. Rep. 33, 63 (2026).","journal-title":"Mol. Med. Rep."},{"key":"120_CR60","doi-asserted-by":"publisher","first-page":"e91863","DOI":"10.1172\/jci.insight.91863","volume":"2","author":"DS Edgerton","year":"2017","unstructured":"Edgerton, D. S. et al. Insulin\u2019s direct hepatic effect explains the inhibition of glucose production caused by insulin secretion. JCI Insight 2, e91863 (2017).","journal-title":"JCI Insight"},{"key":"120_CR61","doi-asserted-by":"publisher","first-page":"702","DOI":"10.3390\/cells9030702","volume":"9","author":"N Kodani","year":"2020","unstructured":"Kodani, N. & Nakae, J. Tissue-specific metabolic regulation of FOXO-binding protein: FOXO does not act alone. Cells 9, 702 (2020).","journal-title":"Cells"},{"key":"120_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/nyas.13435","volume":"1411","author":"M Hatting","year":"2018","unstructured":"Hatting, M. et al. Insulin regulation of gluconeogenesis. Ann. N. Y. Acad. Sci. 1411, 21\u201335 (2018).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"120_CR63","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4093\/dmj.2019.0200","volume":"44","author":"HS Han","year":"2020","unstructured":"Han, H. S., Kwon, Y. & Koo, S. H. Role of CRTC2 in metabolic homeostasis: key regulator of whole-body energy metabolism? Diabetes Metab. J. 44, 498\u2013508 (2020).","journal-title":"Diabetes Metab. J."},{"key":"120_CR64","doi-asserted-by":"publisher","first-page":"13125","DOI":"10.1074\/jbc.RA118.002196","volume":"293","author":"JM Lee","year":"2018","unstructured":"Lee, J. M. et al. The SMILE transcriptional corepressor inhibits cAMP response element-binding protein (CREB)-mediated transactivation of gluconeogenic genes. J. Biol. Chem. 293, 13125\u201313133 (2018).","journal-title":"J. Biol. Chem."},{"key":"120_CR65","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cell.2017.03.001","volume":"169","author":"K Sharabi","year":"2017","unstructured":"Sharabi, K. et al. Selective chemical inhibition of PGC-1\u03b1 gluconeogenic activity ameliorates type 2 diabetes. Cell 169, 148\u2013160.e15 (2017).","journal-title":"Cell"},{"key":"120_CR66","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.kint.2019.08.021","volume":"97","author":"M Nakamura","year":"2020","unstructured":"Nakamura, M. et al. Insulin promotes sodium transport but suppresses gluconeogenesis via distinct cellular pathways in human and rat renal proximal tubules. Kidney Int. 97, 316\u2013326 (2020).","journal-title":"Kidney Int."},{"key":"120_CR67","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cmet.2021.03.007","volume":"33","author":"GF Lewis","year":"2021","unstructured":"Lewis, G. F. et al. Direct and indirect control of hepatic glucose production by insulin. Cell Metab. 33, 709\u2013720 (2021).","journal-title":"Cell Metab."},{"key":"120_CR68","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3390\/biomedicines10081899","volume":"10","author":"SM Najjar","year":"2022","unstructured":"Najjar, S. M. et al. Regulation of insulin clearance by non-esterified fatty acids. Biomedicines 10, 1899 (2022).","journal-title":"Biomedicines"},{"key":"120_CR69","first-page":"E1209","volume":"273","author":"V Chandramouli","year":"1997","unstructured":"Chandramouli, V. et al. Quantifying gluconeogenesis during fasting. Am. J. Physiol. 273, E1209\u2013E1215 (1997).","journal-title":"Am. J. Physiol."},{"key":"120_CR70","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1042\/bj3620513","volume":"362","author":"E van Schaftingen","year":"2002","unstructured":"van Schaftingen, E. & Gerin, I. The glucose-6-phosphatase system. Biochem. J. 362, 513\u2013532 (2002).","journal-title":"Biochem. J."},{"key":"120_CR71","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3803\/EnM.2021.1364","volume":"37","author":"JH Choi","year":"2022","unstructured":"Choi, J. H. & Kim, M. S. Homeostatic regulation of glucose metabolism by the central nervous system. Endocrinol. Metab. 37, 9\u201325 (2022).","journal-title":"Endocrinol. Metab."},{"key":"120_CR72","doi-asserted-by":"crossref","unstructured":"Ritter, S. Monitoring and maintenance of brain glucose supply: importance of hindbrain catecholamine neurons in this multifaceted task. in Appetite and Food Intake: Central Control 2nd edn (ed Harris, R. B. S.) Ch. 9 (CRC Press, Boca Raton, 2017).","DOI":"10.1201\/9781315120171-9"},{"key":"120_CR73","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00125-020-05369-0","volume":"64","author":"RJ McCrimmon","year":"2021","unstructured":"McCrimmon, R. J. Consequences of recurrent hypoglycaemia on brain function in diabetes. Diabetologia 64, 971\u2013977 (2021).","journal-title":"Diabetologia"},{"key":"120_CR74","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1016\/j.radcr.2023.09.035","volume":"18","author":"M Hamid","year":"2023","unstructured":"Hamid, M., Benmoh, Y. & Bourazza, A. Hypoglycemic encephalopathy with extensive brain injuries: a case report. Radiol. Case Rep. 18, 4495\u20134498 (2023).","journal-title":"Radiol. Case Rep."},{"key":"120_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82838-5","volume":"11","author":"JS Yun","year":"2021","unstructured":"Yun, J. S. et al. Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes. Sci. Rep. 11, 4305 (2021).","journal-title":"Sci. Rep."},{"key":"120_CR76","doi-asserted-by":"publisher","first-page":"e771","DOI":"10.1097\/MD.0000000000000771","volume":"94","author":"CJ Shih","year":"2015","unstructured":"Shih, C. J. et al. Association of hypoglycemia with incident chronic kidney disease in patients with type 2 diabetes: a nationwide population-based study. Medicine 94, e771 (2015).","journal-title":"Medicine"},{"key":"120_CR77","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1152\/japplphysiol.01202.2012","volume":"114","author":"CA Emhoff","year":"2013","unstructured":"Emhoff, C. A. et al. Gluconeogenesis and hepatic glycogenolysis during exercise at the lactate threshold. J. Appl. Physiol. 114, 297\u2013306 (2013).","journal-title":"J. Appl. Physiol."},{"key":"120_CR78","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S1016-8478(23)10717-5","volume":"23","author":"SH Suh","year":"2007","unstructured":"Suh, S. H., Paik, I. Y. & Jacobs, K. Regulation of blood glucose homeostasis during prolonged exercise. Mol. Cells 23, 272\u2013279 (2007).","journal-title":"Mol. Cells"},{"key":"120_CR79","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1113\/JP271934","volume":"594","author":"CC Webster","year":"2016","unstructured":"Webster, C. C. et al. Gluconeogenesis during endurance exercise in cyclists habituated to a long-term low carbohydrate high-fat diet. J. Physiol. 594, 4389\u20134405 (2016).","journal-title":"J. Physiol."},{"key":"120_CR80","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.3390\/ijms22073344","volume":"22","author":"SV Seal","year":"2021","unstructured":"Seal, S. V. & Turner, J. D. The \u2018Jekyll and Hyde\u2019 of gluconeogenesis: early life adversity, later life stress, and metabolic disturbances. Int. J. Mol. Sci. 22, 3344 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"120_CR81","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12272-013-0018-5","volume":"36","author":"KJ Oh","year":"2013","unstructured":"Oh, K. J., Han, H. S., Kim, M. J. & Koo, S. H. Transcriptional regulators of hepatic gluconeogenesis. Arch. Pharm. Res. 36, 189\u2013200 (2013).","journal-title":"Arch. Pharm. Res."},{"key":"120_CR82","doi-asserted-by":"publisher","first-page":"155310","DOI":"10.1016\/j.metabol.2022.155310","volume":"136","author":"Z Liu","year":"2022","unstructured":"Liu, Z. et al. Recurrent hypoglycemia increases hepatic gluconeogenesis without affecting glycogen metabolism or systemic lipolysis in rat. Metabolism 136, 155310 (2022).","journal-title":"Metabolism"},{"key":"120_CR83","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.3390\/jcm10112412","volume":"10","author":"W Wasyluk","year":"2021","unstructured":"Wasyluk, W. & Zwolak, A. Metabolic alterations in sepsis. J. Clin. Med. 10, 2412 (2021).","journal-title":"J. Clin. Med."},{"key":"120_CR84","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/cbf.3637","volume":"39","author":"WB de Souza Galia","year":"2021","unstructured":"de Souza Galia, W. B. et al. Gluconeogenesis is reduced from alanine, lactate and pyruvate, but maintained from glycerol, in liver perfusion of rats with early and late sepsis. Cell Biochem. Funct. 39, 754\u2013762 (2021).","journal-title":"Cell Biochem. Funct."},{"key":"120_CR85","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.eclnm.2008.07.005","volume":"4","author":"L Sobotka","year":"2009","unstructured":"Sobotka, L. & Soeters, P. Basics in clinical nutrition: metabolic response to injury and sepsis. e-SPEN Eur. e-J. Clin. Nutr. Metab. 4, e1\u2013e3 (2009).","journal-title":"e-SPEN Eur. e-J. Clin. Nutr. Metab."},{"key":"120_CR86","doi-asserted-by":"publisher","first-page":"E575","DOI":"10.21037\/jtd.2016.05.63","volume":"8","author":"K Nugent","year":"2016","unstructured":"Nugent, K., Edriss, H. & Selvan, K. Hyperglycemia and outcomes in patients with sepsis. J. Thorac. Dis. 8, E575\u2013E577 (2016).","journal-title":"J. Thorac. Dis."},{"key":"120_CR87","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/dom.12668","volume":"18","author":"JB Harp","year":"2016","unstructured":"Harp, J. B., Yancopoulos, G. D. & Gromada, J. Glucagon orchestrates stress-induced hyperglycaemia. Diab. Obes. Metab. 18, 648\u2013653 (2016).","journal-title":"Diab. Obes. Metab."},{"key":"120_CR88","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/BF01799108","volume":"19","author":"G van den Berghe","year":"1996","unstructured":"van den Berghe, G. Disorders of gluconeogenesis. J. Inherit. Metab. Dis. 19, 470\u2013477 (1996).","journal-title":"J. Inherit. Metab. Dis."},{"key":"120_CR89","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1055\/s-0040-1722685","volume":"52","author":"J Becker","year":"2021","unstructured":"Becker, J. et al. Cytosolic phosphoenolpyruvate carboxykinase deficiency: cause of hypoglycemia-induced seizure and death. Neuropediatrics 52, 398\u2013402 (2021).","journal-title":"Neuropediatrics"},{"key":"120_CR90","doi-asserted-by":"publisher","first-page":"e230365","DOI":"10.1530\/JOE-23-0365","volume":"261","author":"ER McGlone","year":"2024","unstructured":"McGlone, E. R., Bloom, S. R. & Tan, T. M. Glucagon resistance and metabolic-associated steatotic liver disease: a review of the evidence. J. Endocrinol. 261, e230365 (2024).","journal-title":"J. Endocrinol."},{"key":"120_CR91","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.2337\/db24-0305","volume":"73","author":"MFG Gr\u00f8ndahl","year":"2024","unstructured":"Gr\u00f8ndahl, M. F. G. et al. Glucagon clearance is decreased in chronic kidney disease but preserved in liver cirrhosis. Diabetes 73, 1641\u20131647 (2024).","journal-title":"Diabetes"},{"key":"120_CR92","doi-asserted-by":"publisher","first-page":"1061682","DOI":"10.3389\/fendo.2022.1061682","volume":"13","author":"T Pixner","year":"2023","unstructured":"Pixner, T. et al. The relationship between glucose and the liver-alpha cell axis\u2014a systematic review. Front. Endocrinol. 13, 1061682 (2023).","journal-title":"Front. Endocrinol."},{"key":"120_CR93","doi-asserted-by":"publisher","first-page":"1645041","DOI":"10.3389\/fendo.2025.1645041","volume":"16","author":"SH Lee","year":"2025","unstructured":"Lee, S. H., Park, H. Y., Yun, J. H. & Do, E. K. Glucagon in metabolic disease: a mini-review of emerging multi-organ roles beyond glycemic control. Front. Endocrinol. 16, 1645041 (2025).","journal-title":"Front. Endocrinol."},{"key":"120_CR94","doi-asserted-by":"publisher","first-page":"e162255","DOI":"10.1172\/jci.insight.162255","volume":"8","author":"C Lubaczeuski","year":"2023","unstructured":"Lubaczeuski, C. et al. Time-dependent effects of endogenous hyperglucagonemia on glucose homeostasis and hepatic glucagon action. JCI Insight 8, e162255 (2023).","journal-title":"JCI Insight"},{"key":"120_CR95","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.tem.2024.05.006","volume":"35","author":"E Barroso","year":"2024","unstructured":"Barroso, E., Jurado-Aguilar, J., Wahli, W., Palomer, X. & V\u00e1zquez-Carrera, M. Increased hepatic gluconeogenesis and type 2 diabetes mellitus. Trends Endocrinol. Metab. 35, 1062\u20131077 (2024).","journal-title":"Trends Endocrinol. Metab."},{"key":"120_CR96","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s00125-014-3455-x","volume":"58","author":"ST Chung","year":"2015","unstructured":"Chung, S. T. et al. Increased gluconeogenesis in youth with newly diagnosed type 2 diabetes. Diabetologia 58, 596\u2013603 (2015).","journal-title":"Diabetologia"},{"key":"120_CR97","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/0022-5193(78)90179-0","volume":"73","author":"TP Stein","year":"1978","unstructured":"Stein, T. P. Cachexia, gluconeogenesis and progressive weight loss in cancer patients. J. Theor. Biol. 73, 51\u201359 (1978).","journal-title":"J. Theor. Biol."},{"key":"120_CR98","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/s42255-025-01265-2","volume":"7","author":"Y Liu","year":"2025","unstructured":"Liu, Y. et al. Hepatic gluconeogenesis and PDK3 upregulation drive cancer cachexia in flies and mice. Nat. Metab. 7, 823\u2013841 (2025).","journal-title":"Nat. Metab."},{"key":"120_CR99","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.mehy.2006.04.048","volume":"67","author":"GP Bongaerts","year":"2006","unstructured":"Bongaerts, G. P., van Halteren, H. K., Verhagen, C. A. & Wagener, D. J. Cancer cachexia demonstrates the energetic impact of gluconeogenesis in human metabolism. Med. Hypotheses 67, 1213\u20131222 (2006).","journal-title":"Med. Hypotheses"},{"key":"120_CR100","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jamda.2016.04.019","volume":"17","author":"JM Argil\u00e9s","year":"2016","unstructured":"Argil\u00e9s, J. M., Campos, N., Lopez-Pedrosa, J. M., Rueda, R. & Rodriguez-Ma\u00f1as, L. Skeletal muscle regulates metabolism via interorgan crosstalk: roles in health and disease. J. Am. Med. Dir. Assoc. 17, 789\u2013796 (2016).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"120_CR101","doi-asserted-by":"publisher","first-page":"7037","DOI":"10.3390\/ijms25137037","volume":"25","author":"M Hole\u010dek","year":"2024","unstructured":"Hole\u010dek, M. Origin and roles of alanine and glutamine in gluconeogenesis in the liver, kidneys, and small intestine under physiological and pathological conditions. Int. J. Mol. Sci. 25, 7037 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"120_CR102","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/mrc.5419","volume":"62","author":"GA Nagana Gowda","year":"2024","unstructured":"Nagana Gowda, G. A., Lusk, J. A. & Pascua, V. Intracellular pyruvate-lactate-alanine cycling detected using real-time nuclear magnetic resonance spectroscopy of live cells and isolated mitochondria. Magn. Reson. Chem. 62, 84\u201393 (2024).","journal-title":"Magn. Reson. Chem."},{"key":"120_CR103","doi-asserted-by":"publisher","first-page":"929572","DOI":"10.3389\/fendo.2022.929572","volume":"13","author":"D Aguilar-Cazares","year":"2022","unstructured":"Aguilar-Cazares, D. et al. The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment. Front. Endocrinol. 13, 929572 (2022).","journal-title":"Front. Endocrinol."},{"key":"120_CR104","doi-asserted-by":"publisher","first-page":"6028","DOI":"10.3390\/cancers14246028","volume":"14","author":"E Kocianova","year":"2022","unstructured":"Kocianova, E., Piatrikova, V. & Golias, T. Revisiting the Warburg effect with focus on lactate. Cancers 14, 6028 (2022).","journal-title":"Cancers"},{"key":"120_CR105","doi-asserted-by":"publisher","first-page":"1621358","DOI":"10.3389\/fphys.2025.1621358","volume":"16","author":"S Kumar","year":"2025","unstructured":"Kumar, S., Sahu, N., Jawaid, T., Jayasingh Chellammal, H. S. & Upadhyay, P. Dual role of lactate in human health and disease. Front. Physiol. 16, 1621358 (2025).","journal-title":"Front. Physiol."},{"key":"120_CR106","first-page":"311","volume":"217","author":"MN Berry","year":"1987","unstructured":"Berry, M. N., Phillips, J. W., Henly, D. C. & Clark, D. G. Evidence that stimulation of gluconeogenesis by fatty acids is mediated through thermodynamic mechanisms. FEBS Lett. 217, 311\u2013314 (1987).","journal-title":"FEBS Lett."},{"key":"120_CR107","unstructured":"Edwards, M. & Mohiuddin, S. S. Biochemistry, lipolysis. in StatPearls (StatPearls Publishing, Treasure Island, FL, 2023)."},{"key":"120_CR108","doi-asserted-by":"publisher","first-page":"18017","DOI":"10.1074\/jbc.RA119.011033","volume":"294","author":"KM Kalemba","year":"2019","unstructured":"Kalemba, K. M. et al. Glycerol induces G6pc in primary mouse hepatocytes and is the preferred substrate for gluconeogenesis both in vitro and in vivo. J. Biol. Chem. 294, 18017\u201318028 (2019).","journal-title":"J. Biol. Chem."},{"key":"120_CR109","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2337\/diabetes.55.03.06.db05-1117","volume":"55","author":"S Chevalier","year":"2006","unstructured":"Chevalier, S., Burgess, S. C., Malloy, C. R., Gougeon, R. & Marliss, E. B. The greater contribution of gluconeogenesis to glucose production in obesity is related to increased whole-body protein catabolism. Diabetes 55, 675\u2013681 (2006).","journal-title":"Diabetes"},{"key":"120_CR110","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1210\/jc.2003-031941","volume":"89","author":"A Gastaldelli","year":"2004","unstructured":"Gastaldelli, A. et al. Separate contribution of diabetes, total fat mass, and fat topography to glucose production, gluconeogenesis, and glycogenolysis. J. Clin. Endocrinol. Metab. 89, 3914\u20133921 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"120_CR111","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.2147\/NSS.S327341","volume":"13","author":"V Kundel","year":"2021","unstructured":"Kundel, V. et al. Measuring visceral adipose tissue metabolic activity in sleep apnea utilizing hybrid 18F-FDG PET\/MRI: a pilot study. Nat. Sci. Sleep. 13, 1943\u20131953 (2021).","journal-title":"Nat. Sci. Sleep."},{"key":"120_CR112","unstructured":"Richard, A. J., White, U., Elks, C. M. & Stephens, J. M. Adipose tissue: physiology to metabolic dysfunction. in Endotext (eds Feingold, K. R. et al.) (MDText.com, South Dartmouth, MA, 2020)."},{"key":"120_CR113","doi-asserted-by":"publisher","first-page":"1322326","DOI":"10.3389\/fendo.2023.1322326","volume":"14","author":"KE Choi","year":"2024","unstructured":"Choi, K. E., Joung, C., Pahk, K. J., Kim, H. & Pahk, K. Metabolic activity of visceral adipose tissue is associated with age-related macular degeneration: a pilot 18F-FDG PET\/CT study. Front. Endocrinol. 14, 1322326 (2024).","journal-title":"Front. Endocrinol."},{"key":"120_CR114","doi-asserted-by":"publisher","first-page":"9453","DOI":"10.3390\/nu7115475","volume":"7","author":"C Saponaro","year":"2015","unstructured":"Saponaro, C., Gaggini, M., Carli, F. & Gastaldelli, A. The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis. Nutrients 7, 9453\u20139474 (2015).","journal-title":"Nutrients"},{"key":"120_CR115","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1530\/JOE-20-0193","volume":"247","author":"RM Pereira","year":"2020","unstructured":"Pereira, R. M. et al. Strength exercise reduces hepatic pyruvate carboxylase and gluconeogenesis in DIO mice. J. Endocrinol. 247, 127\u2013138 (2020).","journal-title":"J. Endocrinol."},{"key":"120_CR116","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.2337\/diabetes.54.7.1942","volume":"54","author":"R Basu","year":"2005","unstructured":"Basu, R., Chandramouli, V., Dicke, B., Landau, B. & Rizza, R. Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes 54, 1942\u20131948 (2005).","journal-title":"Diabetes"},{"key":"120_CR117","doi-asserted-by":"publisher","first-page":"E795","DOI":"10.1152\/ajpendo.00281.2021","volume":"321","author":"E Quaye","year":"2021","unstructured":"Quaye, E. et al. Energy expenditure due to gluconeogenesis in pathological conditions of insulin resistance. Am. J. Physiol. Endocrinol. Metab. 321, E795\u2013E801 (2021).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"120_CR118","doi-asserted-by":"publisher","first-page":"E275","DOI":"10.1152\/ajpendo.2001.281.2.E275","volume":"281","author":"S Song","year":"2001","unstructured":"Song, S., Andrikopoulos, S., Filippis, C., Thorburn, A. W. & Proietto, J. Mechanism of fat-induced hepatic gluconeogenesis: effect of metformin. Am. J. Physiol. Endocrinol. Metab. 281, E275\u2013E282 (2001).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"120_CR119","first-page":"e68390","volume":"16","author":"K Hamed","year":"2024","unstructured":"Hamed, K. et al. Glucagon-like peptide-1 (GLP-1) receptor agonists: exploring their impact on diabetes, obesity, and cardiovascular health through a comprehensive literature review. Cureus 16, e68390 (2024).","journal-title":"Cureus"},{"key":"120_CR120","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","volume":"27","author":"DJ Drucker","year":"2018","unstructured":"Drucker, D. J. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 27, 740\u2013756 (2018).","journal-title":"Cell Metab."},{"key":"120_CR121","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3904\/kjim.2016.233","volume":"34","author":"M Lee","year":"2019","unstructured":"Lee, M. et al. Higher glucagon-to-insulin ratio is associated with elevated glycated hemoglobin levels in type 2 diabetes patients. Korean J. Intern. Med. 34, 1068\u20131077 (2019).","journal-title":"Korean J. Intern. Med."},{"key":"120_CR122","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/jcph.2487","volume":"64","author":"M Myerson","year":"2024","unstructured":"Myerson, M. & Paparodis, R. D. Pharmacotherapy of weight-loss and obesity with a focus on GLP-1 receptor agonists. J. Clin. Pharmacol. 64, 1204\u20131221 (2024).","journal-title":"J. Clin. Pharmacol."},{"key":"120_CR123","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/asj\/sjad211","volume":"44","author":"SH Han","year":"2024","unstructured":"Han, S. H. et al. Public interest in the off-label use of glucagon-like peptide-1 agonists (Ozempic) for cosmetic weight loss: a Google Trends analysis. Aesthet. Surg. J. 44, 60\u201367 (2024).","journal-title":"Aesthet. Surg. J."},{"key":"120_CR124","doi-asserted-by":"publisher","first-page":"102661","DOI":"10.1016\/j.eclinm.2024.102661","volume":"73","author":"H Moll","year":"2024","unstructured":"Moll, H. et al. GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit-harm modelling study. eClinicalMedicine 73, 102661 (2024).","journal-title":"eClinicalMedicine"},{"key":"120_CR125","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jdiacomp.2014.01.012","volume":"28","author":"J Rosenstock","year":"2014","unstructured":"Rosenstock, J. et al. Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S). J. Diab. Complications 28, 386\u2013392 (2014).","journal-title":"J. Diab. Complications"},{"key":"120_CR126","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/dom.12414","volume":"17","author":"PD Home","year":"2015","unstructured":"Home, P. D. et al. Efficacy and tolerability of albiglutide versus placebo or pioglitazone over 1 year in people with type 2 diabetes currently taking metformin and glimepiride: HARMONY 5. Diab. Obes. Metab. 17, 179\u2013187 (2015).","journal-title":"Diab. Obes. Metab."},{"key":"120_CR127","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/dom.12849","volume":"19","author":"ZZ Htike","year":"2017","unstructured":"Htike, Z. Z. et al. Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a systematic review and mixed-treatment comparison analysis. Diab. Obes. Metab. 19, 524\u2013536 (2017).","journal-title":"Diab. Obes. Metab."},{"key":"120_CR128","first-page":"314","volume":"21","author":"N Bobok","year":"2025","unstructured":"Bobok, N. Therapeutic strategies, consequences and prospects of glucagon-like peptide-1 agonists. Int. J. Endocrinol. 21, 314\u2013321 (2025).","journal-title":"Int. J. Endocrinol."},{"key":"120_CR129","doi-asserted-by":"publisher","first-page":"1453825","DOI":"10.3389\/fphar.2024.1453825","volume":"15","author":"J Yang","year":"2024","unstructured":"Yang, J. et al. Tirzepatide\u2019s innovative applications in the management of type 2 diabetes and its future prospects in cardiovascular health. Front. Pharmacol. 15, 1453825 (2024).","journal-title":"Front. Pharmacol."},{"key":"120_CR130","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s10522-025-10278-z","volume":"26","author":"D Yu","year":"2025","unstructured":"Yu, D., Zeng, X., Barzilai, D., Thor, D. & Lyu, Y. X. Bridging expectations and science: a roadmap for the future of longevity interventions. Biogerontology 26, 138 (2025).","journal-title":"Biogerontology"},{"key":"120_CR131","doi-asserted-by":"publisher","first-page":"2640342","DOI":"10.1155\/2018\/2640342","volume":"2018","author":"A Kezic","year":"2018","unstructured":"Kezic, A., Popovic, L. & Lalic, K. mTOR inhibitor therapy and metabolic consequences: where do we stand? Oxid. Med. Cell. Longev. 2018, 2640342, https:\/\/doi.org\/10.1155\/2018\/2640342 (2018).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"120_CR132","doi-asserted-by":"publisher","first-page":"732929","DOI":"10.3389\/fphys.2021.732929","volume":"12","author":"RP Cunningham","year":"2021","unstructured":"Cunningham, R. P. & Porat-Shliom, N. Liver zonation\u2014revisiting old questions with new technologies. Front. Physiol. 12, 732929, https:\/\/doi.org\/10.3389\/fphys.2021.732929 (2021).","journal-title":"Front. Physiol."},{"key":"120_CR133","doi-asserted-by":"publisher","first-page":"10701","DOI":"10.3390\/ijms262110701","volume":"26","author":"E Paolini","year":"2025","unstructured":"Paolini, E., Longo, M., Meroni, M. & Dongiovanni, P. Hepatic zonation in MASLD: old question, new challenge in the era of spatial omics. Int. J. Mol. Sci. 26, 10701 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"120_CR134","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/s42255-025-01269-y","volume":"7","author":"J Okada","year":"2025","unstructured":"Okada, J. et al. Spatial hepatocyte plasticity of gluconeogenesis during the metabolic transitions between fed, fasted and starvation states. Nat. Metab. 7, 1073\u20131091 (2025).","journal-title":"Nat. Metab."},{"key":"120_CR135","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/biology8040079","volume":"8","author":"AL Hunter","year":"2019","unstructured":"Hunter, A. L. & Ray, D. W. Circadian clock regulation of hepatic energy metabolism regulatory circuits. Biology 8, 79 (2019).","journal-title":"Biology"},{"key":"120_CR136","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/nm.2214","volume":"16","author":"EE Zhang","year":"2010","unstructured":"Zhang, E. E. et al. Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis. Nat. Med. 16, 1152\u20131156 (2010).","journal-title":"Nat. Med."},{"key":"120_CR137","doi-asserted-by":"publisher","first-page":"e00048","DOI":"10.1128\/MCB.00048-17","volume":"37","author":"H Kim","year":"2017","unstructured":"Kim, H., Zheng, Z., Walker, P. D., Kapatos, G. & Zhang, K. CREBH maintains circadian glucose homeostasis by regulating hepatic glycogenolysis and gluconeogenesis. Mol. Cell. Biol. 37, e00048\u201317, https:\/\/doi.org\/10.1128\/MCB.00048-17 (2017).","journal-title":"Mol. Cell. Biol."},{"key":"120_CR138","doi-asserted-by":"publisher","first-page":"102708","DOI":"10.1016\/j.jbc.2022.102708","volume":"298","author":"H Xu","year":"2022","unstructured":"Xu, H. et al. Glucagon changes substrate preference in gluconeogenesis. J. Biol. Chem. 298, 102708 (2022).","journal-title":"J. Biol. Chem."},{"key":"120_CR139","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1111\/liv.16077","volume":"44","author":"D Goldberg","year":"2024","unstructured":"Goldberg, D., Buchshtab, N., Charni-Natan, M. & Goldstein, I. Transcriptional cascades during fasting amplify gluconeogenesis and instigate a secondary wave of ketogenic gene transcription. Liver Int. 44, 2964\u20132982 (2024).","journal-title":"Liver Int."},{"key":"120_CR140","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cmet.2024.11.008","volume":"37","author":"A Long","year":"2025","unstructured":"Long, A. et al. A famsin\u2013glucagon axis mediates glucose homeostasis. Cell Metab. 37, 629\u2013639.e6 (2025).","journal-title":"Cell Metab."},{"key":"120_CR141","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.jcmgh.2021.04.017","volume":"12","author":"N Korenfeld","year":"2021","unstructured":"Korenfeld, N. et al. Fasting hormones synergistically induce amino acid catabolism genes to promote gluconeogenesis. Cell. Mol. Gastroenterol. Hepatol. 12, 1021\u20131036 (2021).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"120_CR142","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1007\/s00125-018-4562-x","volume":"61","author":"X Qi","year":"2018","unstructured":"Qi, X. et al. Follicle-stimulating hormone enhances hepatic gluconeogenesis by GRK2-mediated AMPK hyperphosphorylation at Ser485 in mice. Diabetologia 61, 1180\u20131192 (2018).","journal-title":"Diabetologia"},{"key":"120_CR143","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/jdi.13745","volume":"13","author":"B Thorens","year":"2022","unstructured":"Thorens, B. Neuronal regulation of glucagon secretion and gluconeogenesis. J. Diab. Investig. 13, 599\u2013607 (2022).","journal-title":"J. Diab. Investig."},{"key":"120_CR144","doi-asserted-by":"publisher","first-page":"105206","DOI":"10.1016\/j.jbc.2023.105206","volume":"299","author":"N Ziari","year":"2023","unstructured":"Ziari, N. & Hellerstein, M. Measurement of gluconeogenesis by ^2H_2O labeling and mass isotopomer distribution analysis. J. Biol. Chem. 299, 105206 (2023).","journal-title":"J. Biol. Chem."},{"key":"120_CR145","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.2337\/db15-0640","volume":"64","author":"ST Chung","year":"2015","unstructured":"Chung, S. T., Chacko, S. K., Sunehag, A. L. & Haymond, M. W. Measurements of gluconeogenesis and glycogenolysis: a methodological review. Diabetes 64, 3996\u20134010 (2015).","journal-title":"Diabetes"},{"key":"120_CR146","doi-asserted-by":"publisher","first-page":"14419","DOI":"10.1074\/jbc.REV120.012758","volume":"295","author":"AM Shah","year":"2020","unstructured":"Shah, A. M. & Wondisford, F. E. Tracking the carbons supplying gluconeogenesis. J. Biol. Chem. 295, 14419\u201314429 (2020).","journal-title":"J. Biol. Chem."},{"key":"120_CR147","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/ndt\/gfaa302","volume":"37","author":"D Legouis","year":"2022","unstructured":"Legouis, D., Faivre, A., Cipp\u00e0, P. E. & de Seigneux, S. Renal gluconeogenesis: an underestimated role of the kidney in systemic glucose metabolism. Nephrol. Dial. Transplant. 37, 1417\u20131425 (2022).","journal-title":"Nephrol. Dial. Transplant."},{"key":"120_CR148","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1681\/ASN.2021050680","volume":"33","author":"T Verissimo","year":"2022","unstructured":"Verissimo, T., Faivre, A., Rinaldi, A., Lindenmeyer, M. & de Seigneux, S. Decreased renal gluconeogenesis is a hallmark of chronic kidney disease. J. Am. Soc. Nephrol. 33, 810\u2013827 (2022).","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["npj Metabolic Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00120-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00120-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00120-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:03:42Z","timestamp":1784642622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00120-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":148,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["120"],"URL":"https:\/\/doi.org\/10.1038\/s44324-026-00120-6","relation":{},"ISSN":["2948-2828"],"issn-type":[{"value":"2948-2828","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declares no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"28"}}